$3.92
0[0.00%]
At close: Jun 3
$3.92
0[0.00%]
PreMarket: 4:25AM EDT
AbCellera Biologics
(NASDAQ:ABCL)Latest News for AbCellera Biologics Stock (NASDAQ:ABCL)
AbCellera Biologics Stock (NASDAQ: ABCL)
Categories: All
Wednesday, May 08, 2024
Tuesday, May 07, 2024
Monday, April 08, 2024
Monday, March 11, 2024
Thursday, February 22, 2024
Wednesday, February 21, 2024
Tuesday, February 20, 2024
- Recap: AbCellera Biologics Q4 EarningsBenzinga Insights - Feb 20, 2024, 4:30PM
- AbCellera Biologics Q4 2023 GAAP EPS $(0.17) Misses $(0.13) Estimate, Sales $9.18M Beat $8.88M EstimateBenzinga Newsdesk - Feb 20, 2024, 4:26PM
- Earnings Scheduled For February 20, 2024Benzinga Insights - Feb 20, 2024, 6:52AM
Tuesday, December 05, 2023
Thursday, November 09, 2023
Friday, November 03, 2023
- AbCellera Presents New Data On Two T-Cell Engager Programs At SITC 2023Benzinga Newsdesk - Nov 3, 2023, 12:07PM
- AbCellera shares are trading lower after the company reported mixed Q3 financial results.Benzinga Newsdesk - Nov 3, 2023, 9:22AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Nov 3, 2023, 9:05AM
Thursday, November 02, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Nov 2, 2023, 5:31PM
- AbCellera shares are trading lower after the company reported mixed Q3 financial results.Benzinga Newsdesk - Nov 2, 2023, 5:14PM
- AbCellera Biologics Q3 EPS $(0.10) Beats $(0.13) Estimate, Sales $6.60M Miss $11.90M EstimateBenzinga Newsdesk - Nov 2, 2023, 4:25PM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM
Wednesday, November 01, 2023
Friday, October 13, 2023
- Piper Sandler Assumes AbCellera Biologics at Overweight, Announces Price Target of $20Benzinga Newsdesk - Oct 13, 2023, 6:29AM
- Abcellera Biologics On Sept 18 Took Ownership Of Antibody Drug Candidate That Was Discovered By Co As Part Of Its Collaboration With EQRX; Advancing Antibody Drug Candidate Into Ind-enabling StudiesCharles Gross - Oct 13, 2023, 6:08AM
Tuesday, October 03, 2023
Monday, October 02, 2023
Thursday, September 28, 2023
Wednesday, September 27, 2023
Tuesday, September 26, 2023
Thursday, September 21, 2023
Wednesday, September 20, 2023
Tuesday, September 19, 2023
Friday, September 15, 2023
Wednesday, September 13, 2023
Monday, September 11, 2023
Thursday, August 31, 2023
Tuesday, August 22, 2023
Thursday, August 10, 2023
Monday, August 07, 2023
Friday, August 04, 2023
- Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Aug 4, 2023, 12:55PM
- Goldman Sachs Maintains Buy on AbCellera Biologics, Lowers Price Target to $24Benzinga Newsdesk - Aug 4, 2023, 9:11AM
- AbCellera Biologics shares are trading lower after the company reported mixed Q2 financial results.Benzinga Newsdesk - Aug 4, 2023, 8:42AM
- Apple, Fortinet, Microchip Technology And Other Big Stocks Moving Lower In Friday's Pre-Market SessionLisa Levin - Aug 4, 2023, 6:39AM
Thursday, August 03, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Aug 3, 2023, 5:32PM
- AbCellera Biologics Q2 EPS $(0.11) Beats $(0.13) Estimate, Sales $10.06M Miss $12.37M EstimateBenzinga Newsdesk - Aug 3, 2023, 4:45PM
- Earnings Scheduled For August 3, 2023Benzinga Insights - Aug 3, 2023, 6:59AM